Search results
20 mar 2020 · The present narrative review highlights the complex issue of severe hyperandrogenism in female athletes, including whether it is fair to allow women with male levels of testosterone to compete against those with normal female levels.
18 maj 2019 · Moreover, it has been demonstrated that women with polycystic ovary syndrome (PCOS) are overrepresented in elite athletes. PCOS, which is a mild form of hyperandrogenism, is associated with an anabolic body composition including more muscle mass than in non-PCOS women.
Athletes who have experienced these symptoms have shown higher levels of free testosterone, increased levels of androgens and amenorrhea, and may have potentially advantageous biomarkers in terms of sport performance (3,6).
It appears to be unfair to allow female athletes with endogenous testosterone levels in the male range (i.e. 10-20 times higher than normal) to compete against those with normal female androgen levels.
In this opinion piece, we summarize, discuss implications of implementation, and critically evaluate our 2018 evidence-based guideline recommendations for exercise and physical activity in women with polycystic ovary syndrome (PCOS). We developed recommendations as part of a larger international guideline development project.
This article serves to educate strength and conditioning coaches on the influence exercise can have on the various hormonal pathways that are impacted by polycystic ovarian syndrome (PCOS), including insulin resistance, cortisol, testosterone, follicle-stimulating, and luteinizing hormones.
19 maj 2021 · The high prevalence of hyperandrogenism is due mostly to the high prevalence of polycystic ovary syndrome (PCOS) among female athletes, and the high intake of anabolic-androgenic steroids in athletes in general. Other rare causes include disorders in sex differentiation.
